Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
about
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary diseaseEvolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failureBrief report: beta-blocker use among veterans with systolic heart failureNon-cardiac comorbidities in chronic heart failure.Frequent non-cardiac comorbidities in patients with chronic heart failure.Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cellsCarvedilol in the treatment of elderly patients with chronic heart failure.Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary diseaseCoronary artery disease is under-diagnosed and under-treated in advanced lung disease.Cardiac disease in chronic obstructive pulmonary diseaseβ-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.β-blockade: benefits beyond blood pressure reduction?Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.Beta-blocker therapy in patients with left ventricular systolic dysfunction and chronic obstructive lung disease in an ambulatory care setting.beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.Filling the gap between guidelines and clinical practice in heart failure treatment: still a far cry from reality.An old debate still in the β-phase?Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease.
P2860
Q34466749-780B3BA9-B598-49D2-9FC2-93BBA23125ACQ34837191-634746A6-7E73-4ABD-8A63-927DF01E0E85Q35634953-1846A333-FACD-4A82-9146-82825D0701EAQ35771399-A395F368-5339-4CD4-851C-386E598150AAQ35901592-0F33C98B-BEC2-4E85-A014-6784842BE658Q35954727-5DBC0D0D-F602-4CDD-A68E-7F1158B7E69FQ36046585-F4C999B4-91C2-4193-9C2A-E8AC2172F03BQ36422638-ABC7364D-FD41-4C7C-B16C-B6C418723F5FQ36892905-15919BAE-4469-4F62-A48A-E5F33A4F828DQ37047304-7520CF55-0BA2-4F2F-8EED-BC2C856A4F04Q37066051-B86CE522-33DE-4B65-AC1B-BE0925E60343Q37103712-10F9739C-0F91-446C-898F-96EBF11C2E32Q37822723-CB6CE35B-C3D6-467A-B277-EAA5CCB6988DQ37978685-991AC2A3-E7B9-4F5A-B9FF-B29A134DD0A9Q38701409-DBA3D1AB-C5CB-42F6-BC0A-9DDCD5FB7D49Q42794601-4358D504-3E71-4E1A-B185-315859498F21Q45332974-923E09CE-4797-4E56-AC71-9C0EE8305625Q46165199-FFBD510C-7501-425E-88F2-DAFE80AFBE7FQ46951342-DB885CB0-AF7A-4B77-B829-0386BA96AFADQ47658450-28157DF1-ED3F-4CE2-B3ED-4CD4AEBBD7A1Q51773250-F679AD34-5556-4729-93E7-883C2FCF3D52
P2860
Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@en
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@nl
type
label
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@en
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@nl
prefLabel
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@en
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@nl
P2093
P1476
Tolerability of carvedilol in ...... e pulmonary disease or asthma.
@en
P2093
Allan R Glanville
Anne M Keogh
Dermot J McCaffrey
Eugene Kotlyar
Peter S Macdonald
Ruth H Arnold
P304
P356
10.1016/S1053-2498(02)00459-X
P577
2002-12-01T00:00:00Z